These Healthcare stocks are trading higher:
-Regulus Therapeutics Inc (RGLS) stock is trading at $2.63, a rise of $1.25, or 70.94%, on high volume. Regulus Therapeutics gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.50. Regulus Therapeutics next reports earnings on March 28.
-Lantern Pharma Inc (LTRN) stock is trading at $7.45, an increase of $1.13, or 17.89%, on moderate volume. Lantern Pharma Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $26.00. Lantern Pharma Inc next reports earnings on March 18.
-Viracta Therapeutics Inc (VIRX) stock is trading at $1.02, a rise of $0.13, or 15.85%, on high volume. Viracta Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.00.
-Greenwich Lifesciences Inc (GLSI) stock is trading at $20.29, an increase of $2.61, or 15.3%, on high volume. Greenwich Lifesciences Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $36.00. Greenwich Lifesciences Inc next reports earnings on March 29.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Lexaria Bioscience Corp (LEXX) stock is trading at $4.07, a loss of $2.18, or 31.36%, on high volume. Lexaria Bioscience Corp gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.50.
-Caribou Biosciences Inc (CRBU) stock is trading at $5.45, a drop of $1.77, or 24.1%, on high volume. Caribou Biosciences Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.00. Caribou Biosciences Inc next reports earnings on March 14.
-Aslan Pharmaceuticals Ltd (ASLN) stock is trading at $1.28, a loss of $0.35, or 21.47%, on high volume. Aslan Pharmaceuticals Ltd ADR gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00. Aslan Pharmaceuticals Ltd ADR next reports earnings on March 22.
-Virpax Pharmaceuticals Inc (VRPX) stock is trading at $3.94, a decline of $1.01, or 19.6%, on high volume. Virpax Pharmaceuticals Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $20.00. Virpax Pharmaceuticals Inc next reports earnings on March 27.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
